All of the case-control studies described in this review are in support of the hypothesis, demonstrating significant growth of IL-1α, IL-6, IL-8 and TNF-α levels in patients with OPMD when compared to healthy individuals (12-21). The gene discussed is IL1A; the disease is oculopharyngeal muscular dystrophy.